HY-P99441-5mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1449A-10mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1449A-5mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9987-1mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9987-10mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9987-5mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-1mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-10mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-100mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-25mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-5mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-115524-50mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9914-1mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9914-5mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9940-1mg
|
MedChemexpress LLC
|
Emicizumab [CAS 1610943-06-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-1mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-10mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-5mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-1mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-10mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-5mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99019-1mg
|
MedChemexpress LLC
|
Fremanezumab [CAS 1655501-53-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99019-10mg
|
MedChemexpress LLC
|
Fremanezumab [CAS 1655501-53-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99019-5mg
|
MedChemexpress LLC
|
Fremanezumab [CAS 1655501-53-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99021-1mg
|
MedChemexpress LLC
|
Galcanezumab [CAS 1578199-75-3]
|
|
Neuroscience-Neuromodulation
|
|